An underground market for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on communication apps, according to recent findings.
Investigational Drug Gaining Traction Via Social Media
Retatrutide, which remains in clinical trials, is being promoted by online personalities for its alleged fat-burning properties. Followers are encouraged to message these accounts directly for source information, while also receiving promotional offers.
Thriving Trade on Social Networks
Additionally, a robust trade exists on Telegram, where groups with thousands of participants share comparison photos, administration instructions and claims of rapid UK delivery. Vendors market the drug there before directing customers to WhatsApp for purchases.
Learning About Retatrutide
This medication is an investigational injectable created by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could assist patients lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.
Medical Professionals Voice Concerns
However, doctors and pharmacists have cautions that the distribution of what is still an unlicensed medication in the UK is a cause for concern and could result in individuals injecting products of unknown origin.
Some professionals stated the demand for the experimental drug could be connected to the increasing price of licensed weight loss products such as Mounjaro.
Legal Position and Enforcement
Marketing the unapproved drug on social media or Telegram is illegal in the United Kingdom, as it is an unlicensed drug that must not be promoted or distributed for personal consumption under the British medical regulations.
Some influencers try to sidestep the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and distribution can still breach medicines, advertising, and customer laws, risking penalties, prosecution or prison.
Service Response and Material Removal
Based on TikTok, the platform has removed violative content and banned related hashtags and query recommendations. The company stated it was committed to keeping the platform secure and allocating resources in strengthening compliance measures.
Online Marketplace Activities
Research also found communities with up to 9,000 participants marketing the experimental drug using Telegram's integrated search feature, which functions like a online catalog. Entering “retatrutide” immediately brings up groups with thousands of members, populated with photos of slimming results, glowing testimonials and detailed guides for mixing or administering at residence.
Within minutes of joining one community, a vendor posted contact information, where most purchases occur. The vendor sent an guidebook and guaranteed shipping within 48 hours. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another provided a image of a alleged testing documentation. None inquired about body mass, medical conditions or previous experience.
Item Details and Pricing
Inside these groups, messages show black plastic packages with Royal Mail labels, stating to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at residence with sterile water, or pre-filled injectors usually priced at 160 pounds for 20 milligrams. When questioned how long a pen should be used, sellers give conflicting answers ranging from a few weeks to “depends on your body”.
Service Moderation and Security Measures
A representative for Telegram stated it actively monitored harmful content on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Cautions
“Individuals are injecting substances they cannot confirm. Although the science behind this drug is valid, these digital products may not include what they advertise,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of an online medical service connected the surge in interest to recent cost increases for approved weight-loss medications such as Mounjaro. “With prices rising, individuals are turning to online platforms. But fake treatments are highly dangerous. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she explained.
Her team has already seen individuals harmed by self-injection from unconfirmed sources. “We understand the disappointment, but purchasing from messaging apps or communication platforms is taking chances with your health,” stated Wyllie. “These materials could be impure or improperly measured.”
Producer Position
A representative from Eli Lilly stated the substance was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they said, adding that any product “falsely representing itself as a Lilly experimental substance not yet approved … may subject users to potentially serious medical dangers”.
